{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-228322","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2024-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.005790+00:00","generated_at":"2026-05-31T00:34:55.370337+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aadi Bioscience wins arbitration; panel finds no breach, no damages to EOC","bullets":["Arbitration panel issued Final Award on Sept 26, 2024, in favor of Aadi Bioscience.","Panel concluded Aadi did not breach the December 2020 EOC License Agreement.","EOC Pharma sought monetary damages; none awarded.","Dispute began in June 2022, centered on alleged failure to provide manufacturing info.","Outcome removes a significant legal overhang for the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-228322","json":"https://secwatch.observer/filing/0001193125-24-228322.json","markdown":"https://secwatch.observer/filing/0001193125-24-228322.md","text":"https://secwatch.observer/filing/0001193125-24-228322.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312524228322/0001193125-24-228322-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312524228322/d871823d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T00:34:55.370337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}